Leadership Overview
Grupo NC has 4 executives leading key functions including strategy, operations, technology, and finance.
Driven by a commitment to sustainable development and innovation, Grupo NC operates with a dual business model serving both B2B and B2C markets, offering healthcare solutions and pharmacy retail services across South America and Asia.
Driven by a commitment to sustainable development and innovation, Grupo NC operates with a dual business model serving both B2B and B2C markets, offering healthcare solutions and pharmacy retail services across South America and Asia.
Leadership Roles at Grupo NC
Luciane Desiato - Chief Executive Officer & Trilingual Executive Secretary
Luciane Desiato, the Chief Executive Officer & Trilingual Executive Secretary at Grupo NC, directs the company's overarching strategy and operational execution. Overseeing all business units, Desiato ensures alignment with Grupo NC's mission of providing innovative healthcare solutions and maintaining excellence in pharmacy retail services across South America and expanding Asian markets. This leadership role involves driving sustainable development initiatives and fostering a culture of continuous improvement throughout the organization. By managing key stakeholder relationships and guiding strategic partnerships, Luciane Desiato secures the company's market position and facilitates growth in both B2B and B2C segments. The executive's focus remains on enhancing operational efficiency and upholding the company's core values of responsible innovation and positive market impact.
Nicole Da Gama - Chief Financial Officer, Executive Assistant
Nicole Da Gama, the Chief Financial Officer, Executive Assistant at Grupo NC, directs the company's financial strategy and fiscal management. Da Gama oversees all financial planning, budgeting, and reporting activities, ensuring the economic health and sustainability of Grupo NC's operations across Brazil, South America, and expanding Asian markets. This leadership position is crucial for supporting the company's dual B2B and B2C business models and its commitment to responsible innovation. By managing capital allocation and financial risk, Nicole Da Gama ensures that investments in healthcare solutions and pharmacy retail services yield optimal returns. The Chief Financial Officer's expertise underpins the company's pursuit of operational excellence and its long-term growth objectives.
Danieli Moralez - Chief Operating Officer
Danieli Moralez, the Chief Operating Officer at Grupo NC, manages the day-to-day operations of the pharmaceutical company. Moralez oversees the integration of B2B and B2C market strategies, ensuring seamless delivery of innovative healthcare solutions and pharmacy retail services. This critical role involves optimizing supply chain logistics and manufacturing processes, directly supporting Grupo NC's commitment to operational excellence. By driving efficiency across all operational facets, Danieli Moralez contributes significantly to the company's expansion into Asian markets while reinforcing its strong presence in Brazil and South America. The Chief Operating Officer's responsibilities include implementing best practices to foster sustainable development and ensuring all operational activities align with the company's core values.
Diego Neufert - Chief Technology Officer
Diego Neufert, the Chief Technology Officer at Grupo NC, architects the company's technological vision and digital transformation initiatives. Neufert leads the development and implementation of innovative healthcare solutions, leveraging cutting-edge technology to enhance both B2B and B2C offerings. This role is pivotal in driving Grupo NC's expansion into Asian markets by establishing robust technological infrastructure and ensuring data security across all operations. By overseeing the integration of advanced systems, Diego Neufert supports the company's commitment to responsible innovation and operational excellence. The Chief Technology Officer's strategic direction ensures that technology effectively underpins the company's growth, sustainability goals, and overall market impact in Brazil and beyond.
Explore Leadership Teams in Manufacturing
AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca is based in the United Kingdom.
Company Leadership

Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries. The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established.
Company Leadership AO
AT
RN
Biophore specializes in the development and manufacturing of niche pharmaceutical products, focusing on APIs and intermediates for the global pharmaceutical industry. The company aims to enable its clients to reach the market quickly, ensuring faster access to patients. With a diverse product range and expertise in complex chemistry, Biophore is a trusted partner for collaborative projects. Their operations are supported by US FDA and EU approved manufacturing facilities, emphasizing quality and innovation.
Company Leadership RL
SA
KK
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership
TK
MF
TN